Hee-Jun Na Selected Research

CT20126

7/2008

CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hee-Jun Na Research Topics

Disease

7	Neoplasms (Cancer) 01/2018 - 05/2005
5	Inflammation (Inflammations) 09/2008 - 07/2004
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 11/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 03/2015
2	Rheumatoid Arthritis 01/2017 - 07/2008
2	Arthritis (Polyarthritis) 07/2008 - 07/2004
2	Experimental Arthritis 07/2008 - 07/2004
1	Wounds and Injuries (Trauma) 01/2019
1	Liver Failure 07/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Glioma (Gliomas) 01/2018
1	Immune System Diseases (Immune Disorders) 01/2017
1	Macular Degeneration (Age-Related Maculopathy) 01/2017
1	Colonic Neoplasms (Colon Cancer) 03/2015
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Myocardial Infarction 11/2013
1	Ischemia 11/2013
1	Vascular Diseases (Vascular Disease) 11/2013
1	Shock 01/2013
1	Carcinogenesis 11/2012
1	Fibrosis (Cirrhosis) 04/2012
1	Endotoxemia 10/2006
1	Atherosclerosis 08/2003

Drug/Important Bio-Agent (IBA)

5	NF-kappa B (NF-kB)IBA 09/2008 - 08/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2014
3	Angiogenesis InhibitorsIBA 03/2015 - 05/2005
3	Proteins (Proteins, Gene)FDA Link 03/2015 - 11/2012
2	Bevacizumab (Avastin)FDA Link 01/2018 - 08/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2004
2	Oxygen (Dioxygen)IBA 01/2014 - 08/2003
2	CollagenIBA 07/2008 - 07/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2008 - 07/2004
2	3,5-dihydroxy-4-methoxybenzoic acidIBA 12/2006 - 10/2006
1	matrigelIBA 01/2019
1	Pharmaceutical PreparationsIBA 08/2017
1	Monoclonal AntibodiesIBA 08/2017
1	Interleukin-2 (IL2)IBA 01/2017
1	EndostatinsIBA 03/2015
1	Glycoproteins (Glycoprotein)IBA 03/2015
1	Caspase 8 (Caspase-8)IBA 01/2014
1	erucylphosphocholineIBA 11/2013
1	miltefosine (Impavido)IBA 11/2013
1	Therapeutic UsesIBA 11/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013
1	InflammasomesIBA 01/2013
1	ThioredoxinsIBA 01/2013
1	LipopolysaccharidesIBA 01/2013
1	human TIPRL proteinIBA 11/2012
1	Carbon MonoxideIBA 04/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2008
1	ChemokinesIBA 07/2008
1	CytokinesIBA 07/2008
1	CT20126IBA 07/2008
1	Gallic AcidIBA 12/2006
1	I-kappa B KinaseIBA 10/2006
1	Proto-Oncogene Proteins p21(ras)IBA 07/2004
1	Farnesyltranstransferase (Farnesyltransferase)IBA 07/2004
1	LB42708IBA 07/2004
1	Messenger RNA (mRNA)IBA 07/2004
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2004
1	hemateinIBA 08/2003

Therapy/Procedure

2	Therapeutics 08/2017 - 11/2013
1	Liver Transplantation 07/2018
1	Transplantation 11/2013